InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: None

Tuesday, 08/18/2020 8:06:52 AM

Tuesday, August 18, 2020 8:06:52 AM

Post# of 403091
The company told us what to expect once rbl testing is complete:

"Should laboratory tests support Brilacidin’s antiviral activity against SARS-CoV-2 (COVID-19), and potentially other RNA viruses, the Company will look to expedite research and clinical development of Brilacidin as a potential antiviral therapy via pharmaceutical partnerships, academic collaborations and government grants."
Taken from Feb 24 PR

Preclinical testing will be completed within 2 weeks. So far from the prs its safe to say that tests support brilacidin's antiviral activity against covid 19.




the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News